Spark Therapeutics LLC, Pfizer deal

The companies partnered to develop and commercialize Spark’s SPK-FIX program to treat hemophilia

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE